bremelanotide
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
2 FDA-registered drug labelers
Lonza AG
Novo Nordisk Production Belgium SA
Why It Matters
Sectors
Health
Downstream UsesNo data available
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS189691-06-3
PubChem CID9941379
DTXSIDDTXSID40893711
FormulaC50H68N14O10
Mol. Weight1025.2 g/mol
SMILESCCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C
Data Sources
99413792026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/bremelanotide/cids/JSON
Archive: data/sources/pubchem_name/bremelanotide.json
CAS 189691-06-32026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json